Kommentar zu „Hypopharynxkarzinom: Lymphknotenmetastasen verringern Überlebenschance“.
[No authors listed]
Laryngorhinootologie. 2024 Jun;103(6):396-397. doi: 10.1055/a-2263-3537. Epub 2024 Jun 3.
Camrelizumab-based induction chemoimmunotherapy in locally advanced stage hypopharyngeal carcinoma: phase II clinical trial.
Gong H, Tian S, Ding H, Tao L, Wang L, Wang J, Wang T, Yuan X, Heng Y, Zhang M, Shi Y, Xu C, Wu C, Wang S, Zhou L.
Nat Commun. 2024 Jun 19;15(1):5251. doi: 10.1038/s41467-024-49121-3.
Clinical and Radiological Evaluation of Hypopharyngeal Carcinoma.
Piazza C, Paderno A, Ravanelli M, Pessina C.
Adv Otorhinolaryngol. 2019;83:35-46. doi: 10.1159/000492306. Epub 2019 Feb 12.
Hypopharynxkarzinom: Lymphknotenmetastasen verringern Überlebenschance.
[No authors listed]
Laryngorhinootologie. 2024 Jun;103(6):396. doi: 10.1055/a-2263-3513. Epub 2024 Jun 3.
Hypopharyngeal cancer.
Wycliffe ND, Grover RS, Kim PD, Simental A Jr.
Top Magn Reson Imaging. 2007 Aug;18(4):243-58. doi: 10.1097/RMR.0b013e3181570c3f.
Imaging of the larynx and hypopharynx.
Becker M, Burkhardt K, Dulguerov P, Allal A.
Eur J Radiol. 2008 Jun;66(3):460-79. doi: 10.1016/j.ejrad.2008.03.027. Epub 2008 May 20.
[Research progress in CT-based radiomics constructing hypopharyngeal cancer and multisystem tumor prediction model].
Wang Y, Lei D.
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2022 Feb;36(2):158-162. doi: 10.13201/j.issn.2096-7993.2022.02.018.
Current management strategy of hypopharyngeal carcinoma.
Chan JY, Wei WI.
Auris Nasus Larynx. 2013 Feb;40(1):2-6. doi: 10.1016/j.anl.2011.11.009. Epub 2012 Jun 17.
Symptoms and Signs, Staging and Co-Morbidity of Hypopharyngeal Cancer.
Bradley PJ.
Adv Otorhinolaryngol. 2019;83:15-26. doi: 10.1159/000492304. Epub 2019 Feb 12.
[Squamous cell carcinoma of the hypopharynx and larynx: evidence-based care].
Fayette J, Pointreau Y, Bourhis J, Lefebvre JL.
Bull Cancer. 2014 May 1;101(5):438-44. doi: 10.1684/bdc.2014.1945.
